Myelofibrosis is a rare bone marrow disorder characterized by excessive fibrosis, or scarring, of the bone marrow.
骨髓纤维化是一种罕见的疾病,其特征是骨髓内纤维组织过度增生。
The patient was diagnosed with
myelofibrosis after experiencing persistent fatigue and anemia.
患者因持续疲劳和贫血而被诊断为骨髓纤维化。
Myelofibrosis can lead to organ failure due to the reduced production of healthy blood cells.
骨髓纤维化可能导致器官功能衰竭,因为健康血细胞的生成减少。
The disease often goes undiagnosed until it progresses to the advanced stage.
这种疾病往往在发展到严重阶段才被发现。
Medical treatment focuses on managing symptoms and reducing the risk of complications.
治疗主要目标是控制症状并降低并发症风险。
Lifestyle changes, such as a healthy diet and exercise, may help manage the condition.
健康饮食和运动等生活方式的改变可能有助于管理此病。
Phlebotomy, or regular blood transfusions, are sometimes necessary to replace lost blood.
定期输血或血小板采集(血透)可能是为了补充失去的血液。
Myelofibrosis patients may benefit from stem cell transplantation in severe cases.
病情严重的骨髓纤维化患者可能需要进行干细胞移植。
The disease has a genetic component, with some forms linked to inherited conditions.
该病有遗传因素,某些类型与遗传性疾病相关。
Cure for
myelofibrosis remains elusive, but research is ongoing to improve management and understanding.
目前对骨髓纤维化的治愈方法尚不明确,但研究仍在努力改善管理和深化理解。
Votrient is for a form of kidney cancer called advanced renal cell carcinoma and the medicine Jakavi is for myelofibrosis, a bone marrow condition.
未经许可,严禁转发。QQ交流群:688169419